| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.006 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |